Station 73
Edward Brown
Age: 74 years old male
Doctor
Patient’s Data
Patient’s Name: Edward Brown
Age: 74-year-old male
Past Medical History:
- Hypertension
- Hyperlipidaemia
- Chronic Kidney Disease (CKD, Stage 3B)
- Metastatic Prostate Cancer –for palliative
- Has DNACPR in place
Drug and Allergy History:
- Ramipril 5 mg OD
- Atorvastatin 20 mg OD
- Butec (Buprenorphine) 10 µg/hour Transdermal Patch: Apply one patch every 7 days
- Paracetamol 1g QDS PRN
- No known drug allergies
QOF and alerts!!: Has no advance care plan in place
Recent Notes/Consultation
Recent notes from oncology
Subject: Discharge Summary for Mr. Edward Brown
Dear GP,
As you may know, Mr. Edward Brown, aged 74, has been under our care for metastatic prostate cancer with bone involvement. He suffers significant chronic pain, particularly in his lower back and hips. He has been started on a Butec 10 µg/hour transdermal patch, to apply one patch every 7 days. Additionally, he remains on paracetamol as needed. If issues arise with the patch not adhering to the skin, we have advised the use of micropore tape to help secure it
Mr. Brown has been counselled regarding the advanced nature of his disease and his prognosis, including the limited time he has remaining.
He is aware of the focus on symptom management and maintaining quality of life. He has now been discharged to the community for palliative management.
Yours sincerely,
Dr Arjun Narayanan MBBS, MRCP (UK), FRCR (Clin Onc), PhD
Consultant Oncologist
District Nurse Review (2 weeks ago)
Routine bloods taken to monitor renal function
Test | Result | Reference Range |
---|---|---|
Serum Creatinine | 200 µmol/L | 64–104 µmol/L (male) |
eGFR | 30 mL/min/1.73m² | >90 mL/min/1.73m² |
Urea | 12 mmol/L | 2.5–7.8 mmol/L |
Potassium | 4.8 mmol/L | 3.5–5.1 mmol/L |
Sodium | 138 mmol/L | 135–145 mmol/L |
Albumin | 35 g/L | 35–50 g/L |
Calcium (Corrected) | 2.25 mmol/L | 2.2–2.6 mmol/L |
Phosphate | 1.4 mmol/L | 0.8–1.5 mmol/L |
Note: Patient booked routine telephone consultation to discuss his current concerns.